Browse all 650 ETFs by category, no search needed
Global 184
US market 62
Country 92
Core UCITS 15
Sector 103
Style & factor 112
Theme 45
Dividend 37
First Trust Indxx Medical Devices (MDEV)Overvalued or undervalued?
Look-through valuation · Global · Expense ratio 0.70 % · ISIN US33738R6392
Price history (since 2021)
Monthly close since 2021. Price shows performance, the valuation verdict is in the look-through above.
Top holdings
| Holding | Weight | vs fair value | Quality |
|---|---|---|---|
| WuXi AppTec Co Ltd H 2359 | 2.8 % | −21.9 % | 75 |
| Baxter International Inc BAX | 2.8 % | −89.6 % | 43 |
| Demant A/S WDH | 2.7 % | n/a | n/a |
| Sysmex Cor 6869 | 2.6 % | n/a | n/a |
| Revvity Inc. RVTY | 2.6 % | −71.9 % | 68 |
| DexCom Inc DXCM | 2.6 % | −56.6 % | 82 |
| Bio-Rad Laboratories Inc BIO | 2.5 % | −50.8 % | 67 |
| Olympus Corp. 7733 | 2.5 % | n/a | n/a |
| Merit Medical Systems Inc MMSI | 2.5 % | −50.1 % | 58 |
| West Pharmaceutical Services Inc WST | 2.4 % | −58.7 % | 71 |
| Agilent Technologies Inc A | 2.4 % | −59.4 % | 70 |
| LivaNova PLC LIVN | 2.4 % | −21.7 % | 55 |
| Waters Corporation WAT | 2.3 % | −70.4 % | 61 |
| Sonova H Ag SOON | 2.3 % | −32.5 % | 71 |
| Carl Zeiss Meditec AG AFX | 2.3 % | +3.1 % | 64 |
| Becton Dickinson and Company BDX | 2.2 % | −46.4 % | 63 |
| Thermo Fisher Scientific Inc TMO | 2.2 % | −49.4 % | 64 |
| Terumo Corp. 4543 | 2.2 % | n/a | n/a |
| Teleflex Incorporated TFX | 2.2 % | −76.8 % | 51 |
| Edwards Lifesciences Corp EW | 2.2 % | −54.8 % | 67 |
| Fisher & Paykel Healthcare Corporation Limited FPH | 2.1 % | n/a | n/a |
| Sartorius Stedim Biotech SA DIM | 2.1 % | −75.4 % | 48 |
| Straumann Holding AG STMN | 2.1 % | −50.2 % | 66 |
| Danaher Corporation DHR | 2.0 % | −50.5 % | 73 |
| Abbott Laboratories ABT | 2.0 % | −32.3 % | 67 |
Fair value and quality per position come from the same valuation as our stock pages. Showing the 25 largest of 49 disclosed positions. "n/a" means the position is not (yet) in our stock universe and does not enter the average.
The 10 most cheaply valued ETFs
Measured against the look-through fair value of the holdings (sufficiently covered funds only). Green means below fair value, red above. Not financial advice.
- 1 CHIU Global X MSCI China Utilities ETF +65.2 % below FV
- 2 CHIQ Global X MSCI China Consumer Disc ETF +56.4 % below FV
- 3 FXI iShares China Large-Cap ETF +52.9 % below FV
- 4 KWEB KraneShares CSI China Internet ETF +44.4 % below FV
- 5 FLCH Franklin FTSE China ETF +38.3 % below FV
- 6 FCFY First Trust S&P 500 Diversified Free Cash Flow ETF +29.9 % below FV
- 7 MCHI iShares MSCI China ETF +28.1 % below FV
- 8 ITB iShares U.S. Home Construction ETF +18.6 % below FV
- 9 TAN Invesco Solar ETF +17.9 % below FV
- 10 C003 Amundi Index Solutions - Amundi DivDAX I UCITS ETF EUR Distributing +8.4 % below FV
Frequently asked about MDEV
Is MDEV overvalued?
What is the fair value of MDEV?
How do you calculate the fair value of an ETF?
Which stocks drive the valuation of MDEV?
What is the expense ratio of MDEV?
How we value this ETF
An ETF has no fair value of its own like a single stock. We build it bottom up: every holding has a fair value and a quality score on our pages. Weighted by portfolio share, that gives First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETF an average of how cheap or expensive its companies currently sit versus fair value, and how high their average quality is.
As of: Sep 4, 2026
The look-through is a computed summary of public fundamentals and is no substitute for your own research.